Elon's Masterplan

The media have no idea why he's really seized control of the federal government...But I've spent 25 years connecting the dots no one else can see -- and Musk's true motives will soon shock almost everyone: Named in this video: the #1 investment to make before May 30 -- when this story is all over the financial media.

BIIB
Biogen Inc
NASDAQ
139.44
Open 139.66 Prev Close 139.98
High 140.80 Low 138.63
Volume 1,436,814 Volume (Avg) 1,588
52 Week High 238.00 52 Week Low 128.51
Market Cap 20.4B PE Ratio 12.47

Shares Stats

Shares Outstanding145,800,000
Shares Float145,620,000
Shares Short3,720,000
Insider Holdings21%
Institution Holdings94.40%

About Biogen Inc

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral sclerosis; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE; BYOOVIZ, a ranibizumab biosimilar referencing LUCENTIS; and TOFIDENCE, a tocilizumab biosimilar referencing ACTEMRA. It offers RITUXAN to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; OCREVUS for relapsing MS and primary progressive MS; LUNSUMIO to treat relapsed or refractory follicular lymphoma; glofitamab for non-Hodgkin's lymphoma; and other anti-CD20 therapies. In addition, the company is developing products for the treatment of MS, Alzheimer's disease and dementia, neuromuscular disorders, Parkinson's disease and movement disorders, neuropsychiatry, and biosimilars. Biogen Inc. has collaboration and license agreements with Merz Therapeutics; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; and Sage Therapeutics, Inc., as well as collaborations with Fujirebio to identify and develop biomarkers for tau pathology in the brain and Stoke Therapeutics, Inc. for the development and commercialization of zorevunersen, a disease modifying medicine for the treatment of Dravet syndrome. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.

General

NameBiogen Inc
TickerBIIB
ExchangeNASDAQ
SectorHealthcare
IndustryDrug Manufacturers - General
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees7,605

Highlights

Analyst Target194.25
Market Cap20,410,500,000
PE Ratio12.47
PEG Ratio6.24
EBITDA2,995,699,968

Financials

Curr Year EPS Estimate15.84
Next Quarter EPS Estimate3.94
Profit Margin17.61%
Operating Margin22.49
Return on Assets0.05
Return on Equity0.10
Revenue9.3B
Earnings Per Share11.18
Revenue Per Share66.46
Gross Profit7,365,499,904
Quarterly Revenue Growth0.03

Valuation

Trailing PE12.47
Forward PE8.90
Price/Sales (Trailing 12 Mt.)2.11
Price/Book (Most Recent Quarter)1.23

Earnings

Most Popular

CDC Considers New Autism Study As Vaccine Safety Debate Persists

The CDC is planning a large study on potential vaccinAutism's links, despite extensive research dismissing any connection.

Three New Patents Reveal Elon and Trump's Secret "Project America" - Ad

Three patents could help President Trump and Elon Musk completely revolutionize a $23 Trillion market. This revolution is about so much more than just self-driving cars. Instead, what Elon's pivoting Tesla towards... Is a market that's 1,000X BIGGER. But a project THIS big can't stay under the radar for long...

Fashion trends for fall: Big shoulders, even bigger coats and a color story to dye for

PARIS (AP) — Paris has spoken, and fashion’s final authority has laid down the law: This coming fall, it’s all about power shoulders, enveloping outerwear, and a color palette that runs from somber to surreal.

13-Second Trump Video Could Trigger AI Shock - Ad

Louis Navellier, the legendary investor who picked Nvidia before shares exploded as high as 3,423%... Just released a video with this 13-second Trump clip about the current AI boom. Please, do NOT buy any AI stock before watching that clip. What President Trump said in that clip could have implications for this AI boom.

COPT Defense Properties Faces Risks: Analyst Sees Uncertainty In Leasing Process Amid Budget Cut Risks

JP Morgan analyst lowers COPT Defense Properties' price target to $29, citing risks from budget cuts, Space Command HQ uncertainty, and slow data center growth.

How to roll over an old 401(k)

Old are a little like the old clothes in the back of your closet. You know you should do something about them, but there they sit, mostly out of sight and mind.

Buffett, Bezos, and Congress Are Betting Big on This One Sector - Ad

This corner of the market is NOT artificial intelligence... Crypto... or any other familiar sector or strategy. Instead...It's a sector that the U.S. Gov't spends 6-TIMES more on, than our own ENTIRE military defense budget. Don't let recent market uncertainty keep you in the dark on this massive opportunity.

Takeaways from our investigation on AI-powered school surveillance

Thousands of American schools are turning to surveillance technology for 24/7 monitoring of student accounts and school-issued devices like laptops and tablets.

Trump Threatens Russia With Sanctions Amid Ukraine Conflict As He Pushes For Peace

President Donald Trump is contemplating imposing extensive sanctions and tariffs on Russia. This move aims to pressure Russia into a peace agreement in the ongoing conflict with Ukraine.

Legendary Investor "Man Who Calls It All" Issues Stunning Final AI Prediction - Ad

Wall Street legend Shah Gilani--dubbed "the man who calls it all"--has predicted market moves for decades . Now, he's revealing his biggest AI pick yet--a little-known stock billionaires are loading up on. Act before March 19 for the best shot at max gains!

Asana Growth Materially Lags Peers, JP Morgan Cuts Price Forecast

Asana's stock (NYSE: ASAN) fell following price target cuts by Wall Street firms despite beating earnings estimates and reporting strong revenue.

This Bear Market Blueprint Could Save Your Retirement - Ad

The crisis we warned about is here--sky-high interest rates, spiraling debt, and AI-driven job losses are reshaping the economy. Waiting for "normal" is a mistake. The rules of wealth have changed. Get my Bear Market Blueprint--a 4-step plan to protect & grow your money. Normally $297--FREE to our subscribers!

TeraWulf Stock Tanks: Death Cross Spells Trouble For Bitcoin Miner

TeraWulf Inc. (NASDAQ:WULF) hit a technical roadblock, forming a Death Cross — a classic bearish signal that suggests trouble ahead.

Tesla Out, Ford In: City Of Baltimore Goes 'In A Different Direction' Reversing EV Deal From 2024

Tesla is losing an EV city fleet deal in Baltimore to Ford. A look at what happened and how politics may have factored into the decision.

Fed Wipes $2 Trillion With Secretive Move - Ad

$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates. According to Dan Ferris, you should consider moving money to a unique "escape" investment right away.

Asian shares are mixed after Wall Street briefly dips more than 10% below its record

TOKYO (AP) — Asian shares were mixed on Wednesday as investors weighed the impact of President Donald Trump’s tariffs after another day of losses on Wall Street.

Alibaba Unveils New AI Chip To Power China's Open-Source Tech Push, Challenge US Chip Giants

Alibaba's new processor, XuanTie C930, boosts China's semiconductor industry by promoting open-source chips & AI acceleration, amid US sanctions.

Trump and Musk's Secret Plan to Redraw America's Borders - Ad

The world's two most powerful men are reclaiming thousands of acres of abandoned land... and it could make millions for those who understand this new map of America.

What's Going On With Kohl's Stock Wednesday?

Kohl's stock may be moving on continued weakness after the company reported fourth-quarter financial results and issued guidance on Tuesday.

Sam Bankman-Fried Says 'When Rubber Meets The Road' On Crypto's Fate Under Trump, Slams Biden's Policies

Disgraced cryptocurrency mogul Sam Bankman-Fried weighed in on the future of digital assets under President Donald Trump’s administration, according to an interview from his prison released Thursday.

Millionaire Trader: "My No. 1 Stock of the Decade" (Revealed Free) - Ad

The stock revealed right here just may be millionaire trader Jeff Clark's favorite stock ever. Because this one stock alone has been responsible for some of the biggest gains he's ever handed my readers... 195% in under a month... 85% in 14 days... 176% in 5 weeks... 120% in under 3 months... 55% in two days... 138% in 8 days... And even 222% in 8 days.

Brazilian authorities suspend the airline involved in last year's crash that killed 62

SAO PAULO (AP) — aviation agency on Tuesday suspended the operating license for local airline Voepass, citing security risks as an investigation continues into a that killed all 62 people on board.

Magnificent 7 Sheds Over $750 Billion In Market Cap In One Day: Is Big Tech's Honeymoon Over? (CORRECTED)

The Magnificent Seven tech companies, including Tesla, which make up 30% of the S&P 500, saw major losses on Monday due to recession fears.

The $20 Trillion Secret of Room 3330 - Ad

Developed by the U.S. military 79 years ago, this controversial technology is about to change American life forever: Elon Musk has already funneled $6 billion to resurrect this covert project -- and the companies involved are minting 10,000 millionaires every week [Goldman Sachs].

China imposes retaliatory tariffs on Canadian farm and food products

BEIJING (AP) — China on Saturday announced retaliatory tariffs on some Canadian farm and food imports, after Canada imposed duties in October on Chinese-made electric vehicles and steel and aluminum products.

UiPath Hit By Slowing ARR Growth, Deal Timing Woes: Analyst Remains Optimistic For AI, Cloud Spark

UiPath Inc (NYSE: PATH) stock declined on weak Q4 revenue and Q1 guidance. Needham analyst reiterated Hold. Deal delays and uncertainty in US Fed segment.

Washington Won't Save You--but This 4-Step Plan Might - Ad

America's economy is unraveling--soaring costs, skyrocketing debt, and Wall Street insiders dumping stocks. This isn't a recession--it's an economic breakdown. Stocks could crash 50%, real estate 40%, and inflation will eat your savings. But history shows: the biggest crashes create the biggest fortunes--if you act now!

House Committee Favors Stablecoin Regulation To 'Strengthen' Dollar: Majority Whip Says CBDCs Against 'American Values'

The House Financial Services Committee held a hearing Tuesday to discuss the need for stablecoin regulation and the harmful impacts of a U.S. Central Bank Digital Currency.

Stocks to Crash on March 16, 2026? Here's Compelling Reason Why - Ad

Perhaps no one on or off Wall Street has been more accurate calling the bull and bear turns of the past 7 years. From the bear markets of 2018 and 2022... to the roaring bull runs of 2021, 2023, and 2024. And now, Marc Chaikin is predicting the next crash will start March 14, 2026. If you have money in the markets, Chaikin's thesis is a must-see.

Elizabeth Warren Raises Questions On Robert F Kennedy's Mar-A-Lago Dinners With Big Pharma: American People Deserve To Know About The Deals Made

Sen. Elizabeth Warren and other lawmakers raised concerns about Robert F. Kennedy Jr.'s private dinners with pharmaceutical executives at Mar-a-Lago, questioning his commitment to reducing corporate influence as Secretary of Health and Human Services.

Just Released: Huge New A.I. Trade - Ad

While everyone's distracted by Nvidia, PLTR & Bitcoin, billionaires have been quietly loading up on this stock. And 99% of Americans have no clue. It could help make a fortune for fast-moving investors, who make their move before March 19.

Panama president calls Trump's talk of 'reclaiming' the Panama Canal a lie

PANAMA CITY (AP) — Panama President José Raúl Mulino on Wednesday accused U.S. President Donald Trump of lying when he said in his address to Congress that his administration was “reclaiming” the Panama Canal.

China's Viral AI Agent Manus Taps Alibaba's Qwen For Local Expansion: What You Need To Know

China's Manus AI, a viral autonomous agent developed by Tencent-backed startup The Butterfly Effect, is partnering with Alibaba's Qwen team to create a localized version as it gains global attention and draws comparisons to DeepSeek.

The Fort Knox Cover-up? What It Means for Gold - Ad

Trump and Musk are demanding answers: Is Fort Knox empty? If the gold is gone, supply collapses, and prices could skyrocket instantly. Right now, I've uncovered 5 major gold predictions that could make this Fort Knox moment even bigger than people realize. One of them is already unfolding--and the window to act is closing fast.

Stock market today: Asian stocks are mixed as week starts with uncertainty over tariffs

BANGKOK (AP) — Asian stocks got a mixed start to trading Monday as uncertainty persisted over what President will do with tariffs.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service